CNNMoney.com
Companies Economy International Corrections Pre-market Trading After-hours Trading Winners/Losers/Actives Bonds Currencies Commodities World Markets Money Magazine Real Estate Taxes Jobs Ask the Expert Money 101 Autos Mutual Funds The Help Desk Loan Center Best Places to Live Ask the Expert Ultimate Guide to Retirement Retirement Calculators Rules of Retirement Best Funds Best Places to Retire Fortune Brainstorm Tech Apple 2.0 Blog Big Tech Blog Sectors and Stocks Tech Talk Resource Guide Small Business Makeovers Questions & Answers Small Business Video 100 Best Places to Launch FSB 100 Fortune Small Business Fortune 500 Brainstorm Tech Investing Management C-Suite Rankings Main Create Portfolio Edit Portfolio Create Alerts Edit Alerts
Andy Serwer Commentary:
Street Life by Andy Serwer Column archive
Serwer: Play drugs, not iPod clones
There's no gain in contesting Apple, but two medical outfits look attractive.
Market insight from Fortune Editor-at-Large Andy Serwer

NEW YORK (Fortune) -- Okay does ANYONE think the Federal Reserve will do anything except leave interest rates alone this week? And will the price of oil and other commodities continue to plummet? Big deal questions....

REAL NETWORKS: The company coming out with a new player to compete with the iPod. (Working with SanDisk ... which is, I guess, disk free.) Going to be more closely linked to RNWK's Rhapsody online music service. Okay here's the rub, all of these plans to compete with iPod are like tiltin' at a windmill. Ain't going to happen people! Folks like iPods, ain't going to switch to no Zune (MSFT's (Charts) new playa.) So I don't think I would get Real (Charts) right now.

NOVARTIS: Want to focus on a couple of Euro drug stocks for y'all. I heard about this play over the weekend, and then I saw Bloomberg had a story on some of them which reinforced my point. And that point is, these stocks are relatively inexpensive on a historical basis. And no wonder, with all the money that has flowed into oil and commodity stocks, these guys have languished, that may be turning around now, (as energy stocks swoon, the money has to go somewhere.) Anyway, Bloomberg is reporting that these stocks are the cheapest they've been in 16 years. Bloomie points out that Novartis, Europe's Number 3 drugmaker, reported a 4.1 percent gain in in its second quarter as higher sales of its heart and cancer medicine offset costs related to its acquisition of Chiron. "The company said earnings and revenue will probably reach a record this year as it introduces four medicines with sales potential of more than $1 billion each." Stock (Charts) has already moved a bit.

FRESENIUS: Same kind of deal here as with Novartis. Fresenius Medical, based in Bad Homburg, Germany, (they bad!) makes kidney dialysis equipment which sadly is a growth business that does well in any environment. Company raised its earnings forecast for the year. Fresenius bought Renal Care Group recently. This stock has moved too lately. Trades here under the FMS (Charts) ticker.

LOOSE CHANGE: So I know I'm the last person on the planet, but I finally saw "Wicked." Very clever, the ultimate back story. Got me thinking, what other stories could you do this to?..... Only on the Upper West Side: Saw some girls with a lemonade stand, sayin' "Buy our lemonade, only $1 dollar to save Duh-far." Cute... And have you heard the new Ben Vaughn album: "Designs in Music." Very 1960s movie soundtrack. Think Bond.

______________________________

E-mail Andy Serwer at serwer@fortunemail.com

Stock picks, stock news, stock advice  Top of page

YOUR E-MAIL ALERTS
Follow the news that matters to you. Create your own alert to be notified on topics you're interested in.

Or, visit Popular Alerts for suggestions.
Manage alerts | What is this?
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.